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Quiescent adult stem cells reside in specialized
niches where they become activated to proliferate
and differentiate during tissue homeostasis and in-
jury. How stem cell quiescence is governed is poorly
understood. We report here that NFATc1 is preferen-
tially expressed by hair follicle stem cells in their
niche, where its expression is activated by BMP
signaling upstream and it acts downstream to tran-
scriptionally repress CDK4 and maintain stem cell
quiescence. As stem cells become activated during
hair growth, NFATc1 is downregulated, relieving
CDK4 repression and activating proliferation. When
calcineurin/NFATc1 signaling is suppressed, phar-
macologically or via complete or conditional NFATc1
gene ablation, stem cells are activated prematurely,
resulting in precocious follicular growth. Our findings
may explain why patients receiving cyclosporine A
for immunosuppressive therapy display excessive
hair growth, and unveil a functional role for cal-
cium-NFATc1-CDK4 circuitry in governing stem cell
quiescence.
INTRODUCTION
The hair follicle (HF) is an excellent model for studying stem cell
activity because it continuously proceeds through rounds of tis-
sue regeneration. This cyclic nature of HF formation requires
a subset of stem cells within a specialized niche called the bulge,
located within the HF outer root sheath (ORS) (Claudinot et al.,
2005; Cotsarelis et al., 1990; Oshima et al., 2001; Taylor et al.,
2000). Following embryonic HF morphogenesis and postnatal
completion of the first round of hair growth (anagen), the cycling
portion of the follicle dies (catagen) regressing up to the bulge
region, where the HF then remains dormant during the resting
phase (telogen) (Figure S1A available online).
The mechanisms by which the bulge niche environment
changes to induce new follicular growth are still unfolding.
BMP inhibitory signals likely emanating from the dermal papillae
(DP) at the base of the HF have been implicated, as have Wnt sig-nals. Both signaling pathways contribute to the stabilization of
b-catenin (Kobielak et al., 2003; Andl et al., 2004; Zhang et al.,
2006; Kobielak et al., 2007), a transcription cofactor for the
TCF/Lef1 family of DNA binding proteins (Clevers, 2006). Acti-
vation of b-catenin/TCF/Lef1 target genes is required for bulge
stem cell activation and maintenance (Andl et al., 2004, 2002;
Huelsken et al., 2001; Kobielak et al., 2003, 2007; Lo Celso
et al., 2004; Lowry et al., 2005; Van Mater et al., 2003; Zhang
et al., 2006). That said, mice conditionally targeted for loss of
BMPR1a (Kobielak et al., 2007) lose the ability of the bulge to
regulate quiescence. These data suggest that the mechanisms
controlling stem cell behavior in the niche are complex.
Microarray profiling has identified genes that are preferentially
expressed in the bulge relative to the proliferative basal cells of
the epidermis (Blanpain et al., 2004; Morris et al., 2004; Tumbar
et al., 2004). One of the upregulated genes in these profiles
and also in an array distinguishing embryonic hair buds from
epidermis (Rhee et al., 2006) is the transcription factor nuclear
factor of activated T cells c1 (NFATc1). NFATc1 (also referred
to as NFAT2) belongs to the NFAT family of transcription factors
which consists of four calcium sensitive members, NFATc1-4,
that are broadly expressed in many different tissues and organs
(Crabtree and Olson, 2002). The subcellular regulation of NFAT
transcription factors can influence their activity, and in many
cell types, NFAT proteins are phosphorylated and confined
to the cytoplasm under basal conditions. In response to in-
creases in intracellular calcium, the serine/threonine phospha-
tase calcineurin becomes activated, dephosphorylating NFAT
proteins and allowing their nuclear translocation. Once in the
nucleus, NFAT proteins in association with other transcription
factors bind to consensus DNA sequences to regulate gene
transcription.
NFATc1’s prominence as a HF stem cell signature gene is
intriguing, given that the immunosuppressant drug cyclosporine
A (CSA), which inhibits calcineurin upstream of NFAT, can induce
hair growth in humans during organ transplantation (Yamamoto
and Kato, 1994) and in mice (Paus et al., 1994; Sawada et al.,
1987). In addition, hair growth is precociously activated in calci-
neurin B1 null skin (Mammucari et al., 2005). A role for NFAT pro-
teins has been postulated for the catagen (destructive) phase of
the hair cycle (Gafter-Gvili et al., 2003), but whether NFAT pro-
teins function in HF stem cells and if so how, remains unex-
plored.Cell 132, 299–310, January 25, 2008 ª2008 Elsevier Inc. 299
To date, mouse genetics have not revealed a role for NFATs in
skin. Epidermal mouse keratinocytes (MKs) in vivo and in vitro
can respond to CSA treatment by blocking nuclear localization
of NFATc2 (Al-Daraji et al., 2002; Canning et al., 2006; Gafter-
Gvili et al., 2003; Yarosh et al., 2005), and NFATs have been po-
sitioned downstream of Notch signaling in cultured epidermal
cells (Mammucari et al., 2005). However, in contrast to NFATc2
(NFAT1) null mice, which are viable and fertile (Hodge et al.,
1996; Xanthoudakis et al., 1996), NFATc1 null mice die early in
embryogenesis, and display defects in cardiac valve, bone and
pancreatic development (de la Pompa et al., 1998; Graef et al.,
2001; Heit et al., 2006; Ranger et al., 1998; Winslow et al., 2006).
Here, we focused on addressing the function of NFATc1 in the
skin. We show that NFATc1 is expressed exclusively in the bulge
region of the HF and using gain- and loss-of function studies, we
identify an inhibitory role for NFATc1 in stem cell activation in the
HF. Moreover, we find that NFATc1-mediated quiescence in-
volves transcriptional repression of the cyclin dependent kinase
4 gene encoding CDK4, which is required for progression
through the G1/S phase of the cell cycle (Sherr and Roberts,
2004). Finally, we find that NFATc1 gene expression is linked up-
stream to BMP signaling. Taken together, these findings provide
significant new insights into how stem cell activation is orches-
trated in the HF.RESULTS
NFATc1 Is Specific to the Quiescent Stem Cell
Niche of the Hair Follicle
To determine whether NFATc1 protein is expressed in the bulge
region of the HF as suggested from our microarray analyses
(Blanpain et al., 2004; Tumbar et al., 2004), we analyzed its
expression by immunofluorescence microscopy (Figure 1 and
Figure S1). Nuclear NFATc1 was first detected during the late
stages of HF morphogenesis (Figures S1B and S1C). As HFs ma-
tured, their midsegments became marked by nuclear NFATc1(+)
(Figure 1A). NFATc1-expressing cells persisted not only through
the growing phase (anagen) of postnatal HFs, but also the resting
(telogen) phase (Figures 1A–1D and Figure S1E).
To more precisely define the cells marked by nuclear NFATc1,
we compared the localization of NFATc1 with other proteins ex-
pressed in the bulge. NFATc1 colocalized with CD34, which is
highly upregulated in quiescent bulge cells and has been used
as a marker for purifying these cells (Blanpain et al., 2004; Fig-
ures 1E and 1I). NFATc1 also overlapped substantially with
Lhx2, required for HF stem cell maintenance (Rhee et al., 2006;
Figures 1F and 1I). In addition, NFATc1(+) cells partially colocal-
ized with TCF3 and Sox9, transcription factors expressed by
bulge cells (Nguyen et al., 2006; Vidal et al., 2005; Figures 1G-1I).
NFATc1 was not detected in the TCF3/Sox9-positive cells of
the lower ORS, thought to be less quiescent stem cells which
have exited the bulge (Oshima et al., 2001). Real-time PCR of
fluorescence activated cell sorted (FACS) skin populations con-
firmed the enrichment of NFATc1 mRNAs in neonatal ORS
(Rendl et al., 2005; Figure 1J) and more specifically in the adult
(a6 integrin+/CD34+) bulge cells at both the 1st and 2nd telogen
stages (Blanpain et al., 2004; Figure 1K).300 Cell 132, 299–310, January 25, 2008 ª2008 Elsevier Inc.Interestingly, in both embryonic and adult skin, NFATc1 pro-
tein and mRNA appeared to be specific for bulge cells (Figure 1).
NFATc1 antibodies did not immunolabel cells in epidermis, se-
baceous glands or dermis (Figures 1A–1H and 1L). Western anal-
ysis confirmed the absence of NFATc1 protein in epidermis
(Figure 1M), and real-time PCR of mRNAs isolated from FACS-
purified skin cell populations revealed high levels of NFATc1
mRNA in P4 ORS and adult a6(+)/CD34(+) bulge cells, in com-
parison to background levels in P4 epidermal, DP, melanocyte
(MC), dermal fibroblast (DF) and adult a6(+)/CD34(-) cells (Fig-
ures 1J and1K). NFATc1 mRNA expression in FACS-purified
a6(+)/CD34(+) bulge MKs was sequentially lost with proliferation
and passage in culture (Figure 1N). Appreciable NFATc1 mRNA
was also not observed in cultured epidermal MKs (Figure 1N).
These data provide compelling evidence that NFATc1 expres-
sion in skin is specific for the HF bulge. The correlation between
nuclear NFATc1 andNFATc1mRNA expression in the bulge also
correlated with NFATc1’s known ability to regulate its own tran-
scription (Pan et al., 2007).
Consistent with the slow-cycling nature of bulge cells, nuclear
NFATc1(+) cells did not colabel the proliferative cells marked by
Ki67 during HF morphogenesis nor during anagen initiation fol-
lowing the first hair cycle (Figures S1G and S1J). In addition,
short pulses of BrdU did not label NFATc1(+) cells either during
the first growth phase (data not shown) nor during the transition
to the second hair cycle (Figure S1H). However, when slow cy-
cling cells were labeled by expression of tetracycline-regulatable
H2B-GFP and then chased for 4 weeks, NFATc1 was observed
in the majority of label retaining cells (LRCs) (Figures S1I and
S1J). Based upon these data, cells marked by nuclear NFATc1
exhibit the characteristics of bulge LRCs.
Cyclosporine A Enhances Stem Cell Activity
in the Bulge Niche
CSA is known to stimulate precocious entry of telogen HFs into
anagen (Paus et al., 1994; Sawada et al., 1987), and is also
known to inhibit NFAT activity (Clipstone and Crabtree, 1992).
These data led us to wonder whether CSA might act on bulge
stem cells to influence the telogen to anagen transition and if
so, how.
To evaluate whether CSA affects the proliferation of bulge cells
during anagen induction, we coadministered CSA and a short
BrdU pulse during the 2nd telogen (Figure 2A). As expected,
within 5 days, the majority of CSA-treated HFs had precociously
entered anagen (Figure 2B). Irrespective of whether the experi-
ments were performed on HFs in their 1st or 2nd hair cycles,
most HFs of CSA-treated skin contained BrdU(+) cells in both
the bulge and the hair germ (Figures 2B, 2C, and Figure S2A).
By contrast, the majority of proliferation at the onset of a sponta-
neous anagen was in the hair germ, while only 10% of HFs
showed proliferative activity in the bulge (Figures 2B, 2C, and
Figure S2A). This was consistent with prior studies showing
that in normal HFs, most slow cycling bulge cells (marked by
pulse-chase with H2BGFP) do not lose their quiescent status
even in the anagen phase of a hair cycle (Tumbar et al., 2004).
Since most CSA-treated bulge cells incorporated BrdU over
multiple days, the effects could not be attributed to an accelera-
tion in the timing at which an otherwise normal bulge undergoes
Figure 1. NFATc1: A Marker of Hair Follicle Stem Cells
(A–D) NFATc1 is expressed the upper HF during anagen at P4 and P27 and at the base of the follicle during telogen (P21 and P49). b4 integrin marks the dermo-
epidermal interface. (C–H) Immunohistochemistry showing NFATc1 colocalization with bulge cell markers, CD34, Lhx2, TCF3, and Sox9. Arrows denote exam-
ples of coexpression. (I) Quantification of the percent of cells with bulge cell markers that colocalize with NFATc1. Data are mean ± SEM. N = 50–176 cells. (J and
K) Real-time PCR analysis of NFATc1 and Sox9 mRNA in FACS isolated populations at P4 (J) and NFATc1 mRNA in the a6/CD34-positive bulge compartment
during the 1st (P19) and 2nd (P49) telogen. (K) Data are mean ± SEM. N = 2 (J) and N = 3 (K) FACS isolated populations. Data are mean ± SEM. Asterisks indicate
significance, p < 0.05. (L) Expression of NFATc1 in the keratin 5 (K5) (+) epidermis at E14.5 or newborn (nb). (M) Isolated P4 epidermis and the dermis (containing
HFs) were subjected to western analysis. (N) Real-time PCR analysis of NFATc1 mRNA from FACS isolated a6(+)/CD34(+) bulge cells, after passage (P1, P4) and
in epidermal keratinocytes (MK). Abbreviations are as follows: DP, dermal papillae; Bu, bulge; ORS, outer root sheath; epi, epidermis; derm, dermis; HG, hair
germ; FB, fibroblasts; MX, matrix; and MC, melanocytes. Dapi staining (blue) shows nuclear localization. The scale bar represents 30 mm.Cell 132, 299–310, January 25, 2008 ª2008 Elsevier Inc. 301
a telogen to anagen transition (Figure 2B). The effects of CSA
also contrasted with hair depilation, another treatment which in-
duces anagen. While depilation resulted in a short-lived burst of
proliferation within the bulge at D2, proliferation in the upper
ORS and surrounding epidermal cells also occurred (Figures
S2B–S2E). We did not observe enhanced epidermal proliferation
with CSA treatment (Figure S2E). Consistent with CSA’s ability to
inhibit calcineurin, required for nuclear NFATc1 localization, CSA
resulted in the disappearance of NFATc1 in the bulge (Figures 2D
and S2I). Nuclear NFATc1 was also lost when bulge cell prolifer-
ation and anagen were precociously induced by depilation
(Figure S2C).
To further explore the relation between calcineurin, NFAT ac-
tivity and bulge cell proliferation, we purified a6(+)/CD34(+) bulge
cells from 1 month old K14-H2BGFP mice and cultured them in
the presence of CSA or cell-permeable VIVIT (11R-VIVIT), a spe-
cific NFAT inhibitor (Aramburu et al., 1998; Noguchi et al., 2004).
CSA or 11R-VIVIT-treated cultures formed larger colonies and
with greater efficiency than vehicle or scrambled VIVIT (11R-
VEET) treated cells (Figures 2F and S3A). The proliferative effects
of CSA on primary bulge cells contrasted with CSA’s growth
suppressive effects observed with cultures of either epidermal
MKs (see also Karashima et al., 1996) or a6(+)CD34() cells,
containing primarily epidermal and non-bulge ORS cells (Figures
S3B and S3C). The ability of CSA and VIVIT to regulate calcium-
sensitive calcineurin/NFAT activity in keratinocytes was con-302 Cell 132, 299–310, January 25, 2008 ª2008 Elsevier Inc.firmed by NFAT reporter gene assays in conjunction with the
calcium ionophore ionomycin (I) and phorbol myristate acetate
(PMA), required together for full activation of NFAT transcrip-
tional activity, and a constitutively active form of NFATc1 (Fig-
ure 2G). Taken together, these results suggest that calcium
signaling and calcineurin activity may also influence NFATc1’s
localization in the bulge and its ability to activate target genes.
NFATc1 Regulates Bulge Stem Cell Quiescence
To determine whether NFATc1 gene expression is essential for
maintaining HF stem cell quiescence, we performed loss of func-
tion studies. Since most NFATc1 null embryos die between
E14.5 and E17.5 (Ranger et al., 1998), skins from NFATc1 null
and control embryos were grafted onto the backs of Nude
mice to monitor their effects on HF morphogenesis and cycling.
HFs formed and underwent cycling normally, including reentry
into telogen in both WT and KO skin grafts (Figure 3C). This
should not have been observed had NFATc1’s effects been
exerted on catagen, the hair cycle stage that Gafter-Gvili et al.
(2003) had postulated to be regulated in CSA-mediated inhibition
of NFATc2.
To address whether loss of NFATc1 affects stem cell activa-
tion, we shaved or dyed hairs at D60 after skin engraftments dur-
ing what is normally an extended telogen phase. By D75 when
WT HFs were in telogen, NFATc1 null HFs had entered anagen,
as visualized by growth of new (white) hairs (Figures 3A and 3B)Figure 2. Impairing Calcineurin/NFAT Signaling Results in Hair Growth and Stem Cell Proliferation
(A) Schematic illustrating the experimental design of CSA experiments.
(B and C) Quantification of anagen induction and BrdU incorporation in follicle stem cells of the bulge (Bu) with cyclosporine A (CSA) treatment. The anagen
control used was the first hair cycle (P18–P25). Data are the mean ± SEM for 50–100 follicles for three individual mice for each time point. Asterisks in (C) indicate
hair shaft autofluorescence.
(D and E) Immunohistochemistry and western analysis of NFATc1 expression following 3 day treatment with vehicle or CSA.
(F) Colony formation and cell number of bulge cells following treatment with vehicle, CSA, 11R-VIVIT, or 11R-VEET. N = 3 experiments with independent sorted
populations.
(G) NFAT reporter activity in response to calcium ionophore (I), phorbol myristate acetate (PMA), caNFATc1, CSA, or 11R-VIVIT. Data are mean ± SEM. N = 3–5
individual experiments for each treatment.
Asterisks indicate significance, p < 0.05. The scale bars represent 30 mm. Dapi staining (blue) shows nuclear localization. Abbreviations are as follows: HF, hair
follicle; Bu, bulge; HG, hair germ; and DP, dermal papillae.
and shedding of old (blue dyed) hairs (Figure 3B). Histological
analyses confirmed that D60 HFs of both genotypes were in
telogen as indicated by the close proximity of DP to bulge
(Figure 3C). However, by D75 only KO HFs were in full anagen
as indicated by the distance of the DP from the bulge due to
new hair growth (Figure 3D). Taken together, these data indi-
cated that the loss of NFATc1 affected hair cycling by shortening
telogen and prompting precocious entry into anagen.
To evaluate whether these aberrations in hair cycling reflect
a specific alteration in bulge stem cells, we conducted BrdU
pulse-chase experiments. Even at P60, after WT and KO HFs
had regressed and were morphologically in telogen, nearly half
of the NFATc1 null bulge cells abnormally incorporated BrdU
during short labeling periods, and most bulge cells failed to retain
label in BrdU-pulse chase experiments (Figure 3E and Fig-
ure S4A). Despite these marked changes in proliferative status
within the bulge, CD34, Sox9, tenascin C and nuclear phos-
pho-Smad 1, 5, 8 (reflective of active BMP signaling) as well as
activated caspase 3, indicative of apoptotic cells (data not
shown), appeared normal in the absence of NFATc1 (Figure 3F
and Figures S4B–S4D). In addition, hair shaft length was slightly
longer in KO follicles (Figure S4G) but long-term grafts main-
tained hair growth (Figure S4H). Thus, the quiescent status and
initiation of hair growth were selectively altered upon loss of
NFATc1, while stem cell self-renewal seemed to be maintained.
Since hair cycling requires mesenchymal-epithelial interac-
tions, it was important to ablate NFATc1 specifically in the skin
epithelial cells. To this end, we bred NFATc1fl/fl mice (to be de-
scribed further elsewhere) to transgenic mice expressing the
Cre recombinase under the control of the keratinocyte-specific
K14 promoter, active by E15.5 (Vasioukhin et al., 1999). NFATc1
cKO mice developed normal HFs (Figure S4F) which lacked
detectable NFATc1 immunolabeling (Figure 3G). In contrast to
the calcineurin B1 cKO (Mammucari et al., 2005), telogen follicles
were maintained in NFATc1 cKO mice (Figure S4J). However,
consistent with the phenotype of the complete NFATc1 null,
while hair germs of WT HFs were still in telogen, a majority of
NFATc1 cKO HFs entered anagen at D56, as revealed by BrdU
labeling in hair germs (Figures 3H and 3I) and the growth of
hairs after shaving (Figure S4I). Quantification documented that
75% of NFATc1 cKO bulges were BrdU-labeled within a
48 hr pulse (Figures 3H and 3I). FACS analysis further substanti-
ated the significant increase of S-phase bulge cells in NFATc1
cKO HFs (Figure 3I). This activation of bulge cell proliferation
was specific as no effect on epidermal proliferation was noted
with loss of NFATc1 (Figure S4E). Together, these data suggest
that in the absence of NFATc1, the slow cycling properties are
selectively lost without perturbing other features of HF stem
cells.
To determine whether NFATc1 can confer slow cycling char-
acteristics upon MKs, we used retroviral delivery to express
a constitutively nuclear form of NFATc1 (caNFATc1; [Neal and
Clipstone, 2003]) in cultured epidermal MKs, which as shown
in Figure 1, lack endogenous NFATc1. caNFATc1 markedly re-
duced the proliferation rate of MKs grown in low-calcium me-
dium, which is favorable to proliferation of WT cells (Figure 4A).
The reduction in proliferation rate was confirmed by BrdU incor-
poration and FACS analyses of cell cycle profiles: caNFATc1-expressing cultures showed 50%–80% fewer BrdU-labeled
(Figure 4B) and S phase MKs (Figure 4C).
The effects of caNFATc1 appeared to be specific for the
reduction in cell cycling rather than an effect on terminal differen-
tiation or apoptosis. caNFATc1 did not appreciably induce termi-
nal differentiation markers transglutaminase (TGM) 1 and 3,
filaggrin and loricrin, which are induced by elevated calcium
(Figure 4D), nor did it increase the percentages of dead or apo-
ptotic cells in MK cultures (Figure 4E).
NFATc1 Represses the Expression of CDK4
in Hair Follicle Stem Cells
The effects of NFATc1 on cell cycle kinetics both in vitro and
in vivo suggested that NFATc1 may control key genes involved
in promoting cell cycle progression. Of the cell cycle genes
which are downregulated in the telogen bulge relative to pro-
liferating progeny (Blanpain et al., 2004; Morris et al., 2004; Tum-
bar et al., 2004), cyclin-dependent kinase 4 (CDK4) stood out.
NFATc2 represses CDK4 promoter activity in T-lymphocytes
(Baksh et al., 2002), and injection of a TAT-p16INK4a protein,
which inhibits CDK4/6, impairs hair growth in mice (Yu et al.,
2003).
By immunohistochemistry, CDK4 appeared to be upregulated
in the telogen to anagen transition of WT HFs, where it appeared
in a few cells at the base of the bulge, in the developing hair germ
and later in the matrix cells of the anagen hair bulb (Figure 5A).
The elevated CDK4 protein during HF stem cell activation was
reflected at the mRNA level, as judged by real-time PCR on
FACS-purified cell populations (Figure 5B). By contrast, NFATc1
null HFs displayed anti-CDK4 staining within the bulge region
even prior to visible signs of anagen progression in vivo
(Figure 5C), and constitutively nuclear caNFATc1 in vitro elicited
a reduction in both CDK4 mRNA (Figure 5D) and protein (Fig-
ure 5E). The regulation of CDK4 expression was at the level of
transcription, since NFATc1 repressed the activity of a luciferase
reporter driven by the wild-type CDK4 promoter but not the pro-
moter harboring mutations in the NFAT binding sites (Baksh
et al., 2002; Figure 5F).
The elevation in CDK4 appeared to be specific for the bulge,
as no change in CDK4 was noted in NFATc1 null epidermis
(Figure S4F). The effects also appeared to be specific for
CDK4, as other cell cycle regulators, including the closely related
homolog CDK6, did not exhibit this behavior (Figures 5B, 5D, and
5E). Importantly, the major downstream target of CDK4/6,
namely retinoblastoma protein (RB), was not phosphorylated in
caNFATc1-infected cells (Figure 5E). Moreover, when a CDK4
transgene was coexpressed with caNFATc1, MK proliferation
and S phase progression were restored to WT levels
(Figure 5G). Taken together, these findings indicated that the
suppression of CDK4 by NFATc1 was sufficient to inhibit G1/S
progression in quiescent stem cells.
Finally, we addressed whether NFATc1 acts downstream of
either of two endogenous signals, BMP and Wnt, known to pro-
mote the telogen to anagen transition. As shown in Figures 6A
and 6B, NFATc1 was still present and nuclear in bulge cells
from mice expressing a constitutively stabilized b-catenin
(DNbcatenin). The HFs of these mice precociously activate ana-
gen, but the bulge stem cells return to quiescence (Lowry et al.,Cell 132, 299–310, January 25, 2008 ª2008 Elsevier Inc. 303
Figure 3. Full and Conditional NFATc1 Deletion Activates Precocious Follicular Growth and Enhanced Stem Cell Activity
(A and B) When shaved or dyed blue during telogen (D60), the KO follicles regrow white hair (A and B) and shed their dyed hairs (B) by D75.
(C and D) Histological analysis of the WT and KO HFs at D60 (C) and D75 (D).
(E) Immunostaining of WT and KO follicles after BrdU label retaining experiments (BrdU pulse at D24–27 postgraft followed by 28 days of chase). Quantification of
bulge cell proliferation (24 hr BrdU pulse) and label retention at D60 in WT and NFATc1 null follicles. Data are mean ± SEM. N = 3 mice for each genotype.304 Cell 132, 299–310, January 25, 2008 ª2008 Elsevier Inc.
2005; see also Lo Celso et al., 2004; van Mater et al., 2003). In
addition, treatment of DNbcatenin mice with CSA resulted in
loss of NFATc1 expression, suggesting that its regulation was
not affected (data not shown). Interestingly, NFATc1 localization
was lost in HFs conditionally targeted for loss of the BMP recep-
tor 1a (Kobielak et al., 2003; Andl et al., 2004), required for BMP
signaling. This was true both for the presumptive bulge of new-
born HFs (Figure 6C) and for 22 day-old HFs of BMPR1a cKO
skin (Figure 6D). Importantly and in contrast to DNbcatenin,
BMPR1a ablation causes bulge cells to lose quiescence (Kobie-
lak et al., 2007).
To address how BMP signaling might affect NFATc1, we first
tested whether exogeneous BMP could activate NFATc1 gene
expression in vitro. As shown in Figure 6E, BMP4 increased
NFATc1mRNA levels by 7- to 9-fold, and this effect was blocked
by the BMP inhibitor, noggin. We next addressed whether
BMP signaling acted directly upon the activity of the NFATc1
promoter (Zhou et al., 2002). NFATc1 promoter activity wasenhanced > 100-fold by BMP4, and again these effects were ab-
rogated by noggin (Figure 6F). Interestingly, despite these pro-
found BMP-specific effects on NFATc1 gene expression, NFAT
reporter activity was only slightly upregulated by BMP4 treat-
ment and required calcium/CN activity (Figure 6G).
DISCUSSION
Our data support a model whereby transcriptional repression of
CDK4 by NFATc1 in WT HFs maintains bulge stem cells in a qui-
escent state in all stages of the hair cycle (Figure 7). Our studies
in vitro and in vivo suggest that BMP signaling and calcineurin
activity are both required for NFATc1 expression. While BMP
signaling affectsNFATc1 gene expression, calcium signaling ac-
tivates NFAT’s action as a transcription factor, suggesting that
both of these upstream activators, BMP and calcium, impinge
on NFATc1’s role in the bulge. As cells are activated to proliferate
and form the new HF, nuclear NFATc1 and NFATc1 geneFigure 4. NFATc1 Inhibits Cellular Proliferation by Blocking G1/S Phase Progression
(A) Retroviral expression of constitutively active NFATc1 (caNFATc1) represses cell proliferation in epidermal MKs. N = 3 individual experiments for each time
point.
(B and C) Quantification of BrdU incorporation as analyzed by FACS or immunostaining (IF) (B) or combined with DNA content (C) in control or caNFATc1 infected
MKs. Representative FACS histogram plot of BrdU immunostaining is shown (left). Data are mean ± SEM. N = 3–4 individual experiments.
(D) Real-time PCR analysis of the epidermal terminal differentiation markers transglutaminase (TGM) 1 and 3, filaggrin, or loricrin in control, caNFATc1-infected
MKs, or cells in high calcium media (Diff. Media). Data are mean ± SEM. N = 3 individual experiments.
(E) FACS analysis of propidium iodide (dead cells) and Annexin V (apoptotic cells) in control, caNFATc1-expressing cells, or cells treated with TNFa (100 ng/ml)
and cycloheximide (CHX) (5ug/ml). Data are mean ± SEM.
Asterisks indicate significance, p < 0.05.(F) Immunostaining for NFATc1 and CD34 in WT and NFATc1 null follicles.
(G) Immunolocalization of NFATc1 in WT and NFATc1 cKO mice at P56.
(H) BrdU immunolabeling after a 48 hr pulse in WT and NFATc1 cKO follicles at P56. Data are mean ± SEM. N = 6 mice for WT and N = 5 mice for NFATc1 cKO.
(I) Quantification of BrdU incorporation and cell cycle analysis of a6(+)/CD34(+) bulge cells from WT and NFATc1 cKO mice. Data are mean ± SEM.
Asterisks indicate significance, p < 0.05. The scale bars represent 30 mm. Dapi staining (blue) shows nuclear localization. Abbreviations are as follows: Bu, bulge;
SG, sebaceous gland; DP, dermal papillae; and HG, hair germ.Cell 132, 299–310, January 25, 2008 ª2008 Elsevier Inc. 305
expression are downregulated and CDK4 expression is upregu-
lated. Finally, when NFATc1 activity is inhibited, either by CSA
treatment or conditional ablation of NFATc1, CDK4 levels are
elevated in the bulge cells and their slow cycling character is
compromised.
CSA has pleiotropic effects on hair growth, although most
studies have concentrated on the notion that CSA enhances hair
growth by preventing the apoptosis that occurs in the catagen
phase of the hair cycle (Gafter-Gvili et al., 2004; Maurer et al.,
1997; Paus et al., 1994). Our studies confirm the ability of CSA
to precociously induce the telogen to anagen transition in resting
HFs (Maurer et al., 1997), and now demonstrate that this transi-
tion is mediated at least in part by promoting proliferation within
the bulge stem cell compartment. Furthermore, our data reveal
that NFATc1, previously unstudied in the skin, is likely responsi-
ble for the effects of CSA on bulge stem cell activation. The stim-
ulation of bulge proliferation in response to CSA or loss of
NFATc1 contrasts with the normal behavior of bulge stem cells,
which typically are slow cycling even during the growing phase of
the hair cycle.
Calcineurin may have additional substrates in the skin that
control catagen or HF retention, since NFATc1 null mice do not
have defects in either process. Calcineurin B1 cKO mice display
alopecia due to the inability to retain telogen HFs, but the down-
stream targets of calcineurin that control this phenotype are un-
known (Mammucari et al., 2005). In addition, other groups have306 Cell 132, 299–310, January 25, 2008 ª2008 Elsevier Inc.postulated that inhibition of calcineurin by CSA may influence HF
regression during the catagen phase of the hair cycle by acting
on NFATc2 nuclear localization (Gafter-Gvili et al., 2004, 2003).
Although NFATc2 null mice are viable and display no overt ab-
normalities on the hair coat (Hodge et al., 1996; Xanthoudakis
et al., 1996), further studies will be required to determine the
mechanisms by which calcineurin and CSA might affect other
substrates in the skin, including NFAT proteins.
It has also been shown that in vitro, calcineurin/NFATc2
regulates terminal differentiation of epidermal MKs by acting
downstream of Notch signaling to activate the p21 promoter
(Santini et al., 2001). NFATc1 did not appear to be expressed
in normal epidermis in vivo, nor did its loss result in any discern-
able defects in the epidermis. Moreover, in keratinocytes in vitro,
activated NFATc1 did not appear to affect terminal differentia-
tion. Thus, both in vivo and in vitro, NFATc1’s function in bulge
cells was distinct from that previously attributed to other NFAT
family members in epidermal cell cultures.
Our data suggest that calcium signaling may contribute to the
regulation of NFATc1 activity in the HF stem cell niche. Calcium
is a well-known regulator of homeostasis and differentiation in
the epidermis in vitro (Hennings et al., 1980; Pillai et al., 1990)
and in vivo (Menon et al., 1985). Intriguingly, the bulge signature
contains a number of genes encoding calcium binding proteins
and ion channels (Blanpain et al., 2004; Morris et al., 2004; Tum-
bar et al., 2004). Future studies will be necessary to dissect theFigure 5. NFATc1 Acts by Repressing CDK4 Expression to Regulate G1/S Progression in Hair Follicle Stem Cells
(A) Anti-CDK4 immunohistochemistry during the telogen (D19) to anagen (D23) transition. Hematoxylin counterstain.
(B) Real-time PCR analysis ofCDK4 andCDK6 mRNA expression in bulge (Bu), all basal (a6+), ORS and matrix (MX) cell populations. Data are mean ± SEM. N = 3
for each sample.
(C) Immunostaining of CDK4 in WT and NFATc1 null follicles.
(D) Expression of cell cycle regulatory genes in control or caNFATc1-expressing cells. Data are mean ± SEM. N = 3 individual experiments.
(E) Western analysis for CDK4, phosphorylated retinoblastoma protein (Rb), and CDK6 in control and caNFATc1 expressing keratinocytes (MKs).
(F) Reporter assays using theCDK4 promoter with NFAT sites (F[B]) or mutated NFAT sites (F[B]-mut) in conjuction with caNFATc1 in MKs. Data are mean ± SEM.
N = 4 individual experiments.
(G) Expression of CDK4 rescues MK growth and S phase progression of cells expressing caNFATc1. N = 3 individual experiments. Data are mean ± SEM.
Abbreviations are as follows: DP, dermal papillae; Bu, bulge; ORS, outer root sheath; SG, sebaceous gland; HG, hair germ; and MX, matrix. Asterisks indicate
significance, p < 0.05. The scale bars represent 30 mm.
mechanisms that regulate calcium signaling in HF stem cells to
regulate their activity and fate.
Despite the identification of bulge stem cell populations based
on their relative quiescence (Claudinot et al., 2005; Cotsarelis
et al., 1990; Trempus et al., 2003; Tumbar et al., 2004), insights
into how quiescence is controlled have only recently begun to
emerge. BMP signaling appears to participate in maintaining qui-
escence within the bulge, as conditional ablation of BMPR1a re-
sults in sustained activation of HF stem cells without apparent
loss of many stem cell features, including Sox9 (Kobielak et al.,
2007). Our data suggest that part of BMPs role in the stem cell
niche may be to control NFATc1 expression. This is supported
by the loss of NFATc1 inBMPR1a cKO skin as well as the marked
elevation in NFATc1 promoter activity and mRNA expression in
BMP4-treated MKs. In this regard, it is noteworthy that 10 puta-
tive SMAD sites reside within the NFATc1 promoter. While
NFATc1 is not likely the only downstream target of BMP signal-
ing, our findings suggest that NFATc1 acts downstream of
BMPR1A signaling in the bulge, where it participates in stem
cell quiescence.In contrast to the effects of BMP signaling and NFATc1 on the
slow-cycling properties of bulge stem cells, inhibition of Wnt sig-
naling seems to act primarily by repressing the differentiation lin-
eages afforded to them (Merrill et al., 2001; Nguyen et al., 2006).
Conversely, while both inhibition of BMP signaling and elevated
Wnt signaling seem to promote the telogen to anagen transition,
gene targeting and transgenic studies are suggestive that they
activate proliferation and lineage commitment by different
means (Gat et al., 1998; Lowry et al., 2005; Kobielak et al.,
2007). Our findings provide insights as to how BMP signaling
may function in controlling the quiescent state of HF stem cells
and in their transition to an activated state at the beginning of
the new hair cycle.
It is intriguing that the epidermis seems to be largely unaf-
fected irrespective of whether NFATc1, BMPR1a or b-catenin
is targeted for ablation. The cell lineage-specific differences in
stem cell regulation between the epidermis and HF may explain
why in the epidermis, quiescence and homeostasis appear to be
regulated by different mechanisms involving EGF receptor sig-
naling (Jensen and Watt, 2006) and NFkB-mediated regulationFigure 6. Expression of NFATc1 in Mutant Mouse Models with Altered Hair Follicle Stem Cell Biology
(A–D) K14 expression (immunolocalization and K14-GFP) and NFATc1 immunolocalization are shown for grafted skin from WT (A), heterozygous stabilized b-cat-
enin (DN) (B), and BMPR1a conditional knockout (cKO) mice (C and D).
(E) Real-time PCR of NFATc1 mRNA levels upon MK treatment with BMP4 and/or the BMP inhibitor, noggin. Data are mean ± SEM. N = 3 individual experiments.
(F) The activity of a 3.6 kb NFATc1 promoter construct following treatment of MKs with BMP4 and/or noggin or PMA (P) and ionomycin (I). Data are mean ± SEM.
N = 3 individual experiments.
(G) NFAT reporter activity upon BMP4, noggin or P/I treatment of MKs. Data are mean ± SEM. N = 3 individual experiments.
Dapi staining (blue) shows nuclear localization. Abbreviations are as follows: Bu, bulge; CN, calcineurin; DP, dermal papillae; HG, hair germ; and epi, epidermis.Cell 132, 299–310, January 25, 2008 ª2008 Elsevier Inc. 307
of CDK4 (Zhang et al., 2005). Given that CSA affects prolifera-
tion, albeit differentially, in both epidermal and HF stem cells, it
will be interesting in the future to evaluate whether calcineurin
signaling and other NFAT proteins play general roles in regulating
stem cell proliferation in other tissues and organs.
In closing, our data suggest that excessive hair growth in hu-
man patients during immunosuppressive therapy involving CSA
treatment might result from inhibition of NFATc1, which in turn
leads to CDK4 expression and HF stem cell activation. If the
mechanism we’ve uncovered in mouse skin occurs in human
HFs, NFATc1 activation could have clinical significance by pro-
viding a possible target for controlling hair growth. Additionally,
by specifically inhibiting or activating NFATc1 in skin, it may be
possible to pharmacologically uncouple the immunosuppressive
and hair growth effects caused by general calcineurin inhibitors
like CSA.EXPERIMENTAL PROCEDURES
Mice, Cyclosporine A Treatments, Grafts, and BrdU Incorporation
NFATc1 null, K14-H2BGFP, DN-bcatenin transgenic mice, and BMPR1a
conditional null mice have been described previously (Gat et al., 1998; Kobie-
lak et al., 2003, 2007; Lowry et al., 2005; Tumbar et al., 2004). A conditional al-
lele of NFATc1 (NFATc1 fl) was generated by flanking exon 3 with loxP sites (to
be described further elsewhere). Exon 3 encodes the NFAT regulatory domain
and deletion results in a null allele (de la Pompa et al., 1998; and data not
shown). NFATc1fl/fl, K14-Cre negative littermates were used as WT controls
for all experiments. Grafting of E15.5 skins was performed as described
(Rhee et al., 2006). For 5-Bromo-20-deoxyuridine (BrdU) (Sigma-Aldrich)
pulse-chase experiments (Blanpain et al., 2004), mice were injected intraper-
itoneally with 50 mg/g BrdU (Sigma-Aldrich) and animals were then sacrificedFigure 7. Model Describing the Role of
NFATc1 Signaling in Bulge Stem Cell Quies-
cence
Calcium/calcineurin (CN) activity and BMP signal-
ing are required to maintain NFATc1 expression
and activity, which transcriptionally represses
CDK4 gene expression. Upon activation of hair
growth, BMP signaling is inhibited, leading to
a loss inNFATc1 expression and relief ofCDK4 re-
pression. When CN signaling is blocked by CSA or
loss of NFATc1 expression, CDK4 is expressed
and precocious activation of the stem cells occurs
within the bulge.
thereafter either directly, or following a chase pe-
riod. For in vivo experiments using CSA, mice
were injected with 100 mg/kg CSA solution (Bed-
ford Laboratories) intraperitoneally daily at P49
for 6 days. Hair dye was used according to manu-
facturer’s directions (L’Oreal).
Retroviral Infection, Cell Culture, and FACS
MSCV-GFP (Vector control), constitutively nuclear
caNFATc1, a NFAT reporter construct and CDK4
retroviral vectors were previously described (Ab-
bott et al., 1998; Baksh et al., 2002; Matsushime
et al., 1992; Neal and Clipstone, 2003). Retrovirus
production is described in the Supplemental
Experimental Procedures. Growth assays using308 Cell 132, 299–310, January 25, 2008 ª2008 Elsevier Inc.infected cells were performed by trypsizing and counting cells with a Z1 Par-
ticle Coulter Counter at indicated intervals. Quantification of BrdU and cell cy-
cle was performed using FACS as described previously (Blanpain et al., 2004).
Differentiation of MKs was induced by adding MK growth media with 1.5 mM
calcium. FACS analysis of apoptosis was performed via Annexin V (Invitrogen)
staining according to manufacturer’s instructions. As a positive control for the
apoptosis experiments, cells were treated with TNFa (100 ng/ml) and cyclo-
heximide (5 mg/ml) for 24 hr prior to staining.
For experiments using cultured bulge stem cells, a6+ cells alone and a6+/
CD34+ bulge cells were FACS purified as described (Blanpain et al., 2004)
from K14-H2BGFPmice. Following FACS isolation, a minimum of 13 105 cells
were seeded onto mitomycin treated fibroblast feeder layers and cultured in
MK growth media with 0.3 mM calcium. After the first passage, the MKs
were treated with vehicle, cyclosporine A (1 mM; Sigma), cell-permeable VIVIT
(11R-VIVIT; 1 mM; Calbiochem), or cell-permeable scrambled VIVIT, (11R-
VEET; generous gift from Masayuki Matsushita and Rockefeller Proteomics
Resource Center) (Noguchi et al., 2004) and analyzed for colony size (>5 cells)
or cell number for the indicated days. No toxicity was noted with the use of
VIVIT on MKs.
Reporter Assays
For CDK4 and NFATc1 promoter reporter assays, MKs were grown to 30%–
40% confluency before Fugene 6 (Roche) reagent-assisted transfections of
cytomegalo virus–Renilla luciferase DNA (control) and the CDK4 or NFATc1
promoter firefly luciferase constructs. The WT CDK4 promoter construct
(F[B]) consisted of –404 to +43 (Baksh et al., 2002). This construct was used
to generate a mutated version of F(B) lacking a NFAT binding site using
the Quickchange Kit (Stratagene) using the complementary oligonucleotide,
F’-CCCGCCTCCCAGAGAGTGCGCGCCTCTTTGGC-30 (mutational changes are
underlined). 48 hr after transfection, luciferase assays with theCDK4 promoter
were performed as described previously (Kaufman et al., 2002).
The NFATc1 promoter construct consisted of 3.7 kb upstream of the
NFATc1 transcriptional start site (Zhou et al., 2002). 48 hr posttransfection,
cells were treated with BMP4 (100 ng/ml; R&D Systems) and/or noggin
(1000 ng/ml; R&D Systems) for 48 hr. 6 hr prior to performing the luciferase
assay, cells were treated with PMA (10 nM) and ionomycin (1 mm).
For NFAT reporter assays, MKs were infected with retroviruses encoding the
NFAT responsive plasmid in control or caNFATc1 infected cells (Abbott et al.,
1998). After 48 hr, PMA (10 nM), ionomycin (1 mM), VIVIT (1 mM) and CSA (1 mM)
were added to the cultures as indicated for 6 hr. PMA acts to induce AP-1 tran-
scription factors and ionomycin increases intracellular calcium, activates
calcineurin, and leads to nuclear translocation of NFAT family members. Lucif-
erase assays were performed as described above.
Histology and Immunofluorescence
Skins were embedded in OCT, frozen, sectioned and fixed in 4% formalde-
hyde. For paraffin sections, skins were incubated in 4% formaldehyde at
4C overnight, dehydrated with a series of increasing concentrations of etha-
nol and xylene, and embedded in paraffin. Paraffin sections were rehydrated in
decreasing concentrations of ethanol and subjected to antigen unmasking in
10 mM Citrate (pH 6.0). For histological analysis, sections were stained with
hematoxylin and eosin. Sections were subjected to immunofluorescence mi-
croscopy. For immunohistochemistry, HRP conjugate secondary antibodies
(Abs) were used followed by the HRP substrate, diaminobenzidine. When
applicable, the MOM Basic Kit (Vector Laboratories) was used to prevent
nonspecific binding of mouse monoclonal Abs. Antibodies and dilutions are
included in the Supplemental Data.
For each type of analysis performed in this study, we assayed for hair cycle
by both histology and proliferation status as indicated by BrdU incorporation
during short pulses.
Statistics
To determine significance between groups, comparisons were made using
Student’s t tests. Analyses of multiple groups were performed using One-
Way ANOVA with Bonferroni’s posttest with GraphPad Prism version for
Macintosh (GraphPad Software). For all statistical tests, the 0.05 level of con-
fidence was accepted for statistical significance.
Supplemental Data
Supplemental Data include four figures and Supplemental Experimental Pro-
cedures and can be found with this article online at http://www.cell.com/cgi/
content/full/132/2/299/DC1/.
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